PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

Human Molecular Genetics

Volumn 23, Issue 15, 2014, Pages 4077-4085

  Pirazzi, Carlo ^a   Valenti, Luca ^c   Motta, Benedetta Maria ^a,c   Pingitore, Piero ^b,d   Hedfalk, Kristina ^b   Mancina, Rosellina Margherita ^a,e   Burza, Maria Antonella ^a   Indiveri, Cesare ^d   Ferro, Yvelise ^e   Montalcini, Tiziana ^e   Maglio, Cristina ^a   Dongiovanni, Paola ^c   Fargion, Silvia ^c   Rametta, Raffaela ^c   Pujia, Arturo ^e   Andersson, Linda ^a   Ghosal, Saswati ^a   Levin, Malin ^a   Wiklund, Olov ^a   Iacovino, Michelina ^f   Borén, Jan ^a   Romeo, Stefano ^a,e   more..

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALABRIA   (Italy)

^e UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^f LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; INSULIN; PALMITIC ACID; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; RETINOL BINDING PROTEIN 4; RETINOL ESTER; RETINOL PALMITATE; RETINYL PALMITATE ESTERASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; RETINOL;

ARTICLE; CARCINOMA CELL; COLON CARCINOMA; ENZYME ACTIVITY; FEMALE; FIBROGENESIS; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; HYDROLYSIS; LIPID ANALYSIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LOSS OF FUNCTION MUTATION; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION; WILD TYPE; ADULT; ANALOGS AND DERIVATIVES; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PRIMARY CELL CULTURE;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATIC STELLATE CELLS; HUMANS; INSULIN; LIPASE; LIPID DROPLETS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PALMITIC ACID; PRIMARY CELL CULTURE; RETINOL-BINDING PROTEINS, PLASMA; VITAMIN A;

EID: 84903996547     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu121     Document Type: Article

References (37)

1. Lee, Y.S. and Jeong, W.I. (2012) Retinoic acids and hepatic stellate cells inliver disease. J. Gastroenterol. Hepatol., 27(Suppl. 2), 75-79.
2. Schreiber, R., Taschler, U., Preiss-Landl, K., Wongsiriroj, N.,Zimmermann, R. and Lass, A. (2012) Retinyl ester hydrolases and their roles in vitamin Ahomeostasis. Biochim. Biophys. Acta, 1821, 113-123.
3. Fields, A.L., Soprano, D.R. and Soprano, K.J. (2007) Retinoids in biologicalcontrol and cancer. J. Cell. Biochem., 102, 886-898.
4. Mongan, N.P. and Gudas, L.J. (2007) Diverse actions of retinoid receptors incancer prevention and treatment. Differentiation, 75, 853-870.
5. Freemantle, S.J., Spinella, M.J. and Dmitrovsky, E. (2003) Retinoids incancer therapy and chemoprevention: promise meets resistance. Oncogene, 22, 7305-7315.
6. Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K.T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E. et al. (1996) Prevention ofsecond primary tumors by an acyclic retinoid, polyprenoic acid, in patientswith hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med., 334, 1561-1567.
7. Muto, Y., Moriwaki, H. and Saito, A. (1999) Prevention of second primarytumors by an acyclic retinoid in patients with hepatocellular carcinoma. N. Engl. J. Med., 340, 1046-1047.
8. Goodman, D.W., Huang, H.S. and Shiratori, T. (1965) Tissue distributionand metabolism of newly absorbed vitamin a in the rat. J. Lipid. Res., 6, 390-396.
9. Blomhoff, R., Rasmussen, M., Nilsson, A., Norum, K.R., Berg, T., Blaner, W.S., Kato, M., Mertz, J.R., Goodman, D.S. and Eriksson, U. (1985) Hepaticretinol metabolism. Distribution of retinoids, enzymes, and binding proteinsin isolated rat liver cells. J. Biol. Chem., 260, 13560-13565.
10. Friedman, S.L. (2008) Hepatic stellate cells: protean, multifunctional, andenigmatic cells of the liver. Physiol. Rev., 88, 125-172.
11. Newcomer, M.E. and Ong, D.E. (2000) Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim. Biophys. Acta, 1482, 57-64.
12. Flower, D.R. (1996) The lipocalin protein family: structure and function. Biochem. J., 318, 1-14.
13. Erikstrup, C., Mortensen, O.H., Nielsen, A.R., Fischer, C.P., Plomgaard, P., Petersen, A.M., Krogh-Madsen, R., Lindegaard, B., Erhardt, J.G., Ullum, H. et al. (2009) RBP-to-retinol ratio, but not total RBP, is elevated in patientswith type 2 diabetes. Diabetes Obes. Metab., 11, 204-212.
14. Mondul, A.M., Yu, K., Wheeler, W., Zhang, H., Weinstein, S.J., Major, J.M., Cornelis, M.C., Männistö, S., Hazra, A., Hsing, A.W. et al. (2011) Genome-wide association study of circulating retinol levels. Hum. Mol. Genet., 20, 4724-4731.
15. Friedman, S.L., Roll, F.J., Boyles, J. and Bissell, D.M. (1985) Hepaticlipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA, 82, 8681-8685.
16. He, S., McPhaul, C., Li, J.Z., Garuti, R., Kinch, L., Grishin, N.V., Cohen, J.C. and Hobbs, H.H. (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceridehydrolysis. J. Biol. Chem., 285, 6706-6715.
17. Pirazzi, C., Adiels, M., Burza, M.A., Mancina, R.M., Levin, M., Sta°hlman, M., Taskinen, M.R., Orho-Melander, M., Perman, J., Pujia, A. et al. (2012) Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol., 57, 1276-1282.
18. Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L.A., Boerwinkle, E., Cohen, J.C. and Hobbs, H.H. (2008) Genetic variationin PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet., 40, 1461-1465.
19. Romeo, S., Sentinelli, F., Dash, S., Yeo, G.S., Savage, D.B., Leonetti, F., Capoccia, D., Incani, M., Maglio, C., Iacovino, M. et al. (2010) Morbidobesity exposes the association between PNPLA3 I148M (rs738409) andindices of hepatic injury in individuals of European descent. Int. J. Obes. (Lond.), 34, 190-194.
20. Sookoian, S. and Pirola, C.J. (2011) Meta-analysis of the influence of I148Mvariant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liverdisease. Hepatology, 53, 1883-1894.
21. Valenti, L., Al-Serri, A., Daly, A.K., Galmozzi, E., Rametta, R., Dongiovanni, P., Nobili, V., Mozzi, E., Roviaro, G., Vanni, E. et al. (2010) Homozygosity for the patatin-like phospholipase-3/adiponutrin I148Mpolymorphism influences liver fibrosis in patients with nonalcoholic fattyliver disease. Hepatology, 51, 1209-1217.
22. Burza, M.A., Pirazzi, C., Maglio, C., Sjoholm, K., Mancina, R.M., Svensson, P.A., Jacobson, P., Adiels, M., Baroni, M.G., Boren, J. et al. (2012)PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellularcarcinoma in obese individuals. Dig. Liver Dis., 44, 1037-1041.
23. Valenti, L., Dongiovanni, P., Ginanni Corradini, S., Burza, M.A. andRomeo, S. (2013) PNPLA3 I148M variant and hepatocellular carcinoma:Acommon genetic variant for a rare disease. Dig. Liver Dis., 45, 619-624.
24. Mello, T., Nakatsuka, A., Fears, S., Davis, W., Tsukamoto, H., Bosron, W.F. and Sanghani, S.P. (2008) Expression of carboxylesterase and lipase genes inrat liver cell-types. Biochem. Biophys. Res. Commun., 374, 460-464.
25. Huang, Y., He, S., Li, J.Z., Seo, Y.K., Osborne, T.F., Cohen, J.C. and Hobbs, H.H. (2010) A feed-forward loop amplifies nutritional regulation ofPNPLA3. Proc. Natl. Acad. Sci. USA, 107, 7892-7897.
26. Hedfalk, K. (2013) Further advances in the production of membrane proteinsin Pichia pastoris. Bioengineered, 4, 363-367.
27. Oberg, F. and Hedfalk, K. (2013) Recombinant production of the humanaquaporins in the yeast Pichia pastoris (invited review). Mol. Membr. Biol., 30, 15-31.
28. Adachi, M., Osawa, Y., Uchinami, H., Kitamura, T., Accili, D. and Brenner, D.A. (2007) The forkhead transcription factor FoxO1 regulates proliferationand transdifferentiation of hepatic stellate cells. Gastroenterology, 132, 1434-1446.
29. Valenti, L., Dongiovanni, P., Ginanni Corradini, S., Burza, M.A. andRomeo, S. (2013) PNPLA3 I148M variant and hepatocellular carcinoma:Acommon genetic variant for a rare disease. Dig. Liver Dis., 45, 619-624.
30. Pingitore, P., Pirazzi, C., Mancina, R.M., Motta, B.M., Indiveri, C., Pujia, A., Montalcini, T., Hedfalk, K. and Romeo, S. (2014) Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation resultsin loss of function. Biochim. Biophys. Acta, 1841, 574-580.
31. Valenti, L., Rumi, M., Galmozzi, E., Aghemo, A., Del Menico, B., DeNicola, S., Dongiovanni, P., Maggioni, M., Fracanzani, A.L., Rametta, R. et al. (2011) Patatin-like phospholipase domain-containing 3 I148Mpolymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology, 53, 791-799.
32. Lee, U.E. and Friedman, S.L. (2011) Mechanisms of hepatic fibrogenesis. Best Pract. Res. Clin. Gastroenterol., 25, 195-206.
33. Amengual, J., Ribot, J., Bonet, M.L. and Palou, A. (2010) Retinoic acidtreatment enhances lipid oxidation and inhibits lipid biosynthesis capacitiesin the liver of mice. Cell. Physiol. Biochem., 25, 657-666.
34. Lake, A.C., Sun, Y., Li, J.L., Kim, J.E., Johnson, J.W., Li, D., Revett, T., Shih, H.H., Liu, W., Paulsen, J.E. et al. (2005) Expression, regulation, andtriglyceride hydrolase activity of Adiponutrin family members. J. Lipid Res., 46, 2477-2487.
35. Valenti, L., Rametta, R., Ruscica,M., Dongiovanni, P., Steffani, L., Motta, B.M., Canavesi, E., Fracanzani, A.L.,Mozzi, E., Roviaro, G. et al. (2012) The I148M PNPLA3 polymorphism influences serum adiponectinin patients with fatty liver and healthy controls. BMC Gastroenterol., 12, 111.
36. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A. et al. (2005) Design and validation of a histological scoring system fornonalcoholic fatty liver disease. Hepatology, 41, 1313-1321.
37. Association, A.D. (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care, 36(Suppl. 1), S67-S74.